Indication
Cystic fibrosis with heterozygous F508del mutation in CFTR gene
Cystic fibrosis with a heterozygous F508del mutation in the CFTR gene describes an autosomal recessive multisystem disorder in patients who possess a single copy of the class II F508del variant paired with another disease-causing mutation on the second CFTR allele. Read more about Cystic fibrosis with heterozygous F508del mutation in CFTR gene
1 drugs 1 manufacturers
Drugs that treat it
Common Cystic fibrosis with heterozygous F508del mutation in CFTR gene therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonCystic fibrosis with a heterozygous F508del mutation in the CFTR gene describes an autosomal recessive multisystem disorder in patients who possess a single copy of the class II F508del variant paired with another disease-causing mutation on the second CFTR allele.
This genetic defect disrupts epithelial chloride and bicarbonate transport, primarily damaging the respiratory, gastrointestinal, hepatobiliary, and reproductive tracts.
Pathophysiologically, the deletion of phenylalanine at position 508 impairs protein folding and trafficking to the apical plasma membrane, causing viscous secretions, impaired mucociliary clearance, chronic sinopulmonary infections, progressive bronchiectasis, and exocrine pancreatic insufficiency.
- oklahoma.gov
Cystic fibrosis with a heterozygous F508del mutation in the CFTR gene describes an autosomal recessive multisystem disorder in patients who possess a single copy of the class II F508del variant paired with another disease-causing mutation on the second CFTR allele This genetic defect disrupts epithelial chloride and bicarbonate transport, primarily damaging the respiratory, gastrointestinal, hepatobiliary, and reproductive tracts Pathophysiologically, the deletion of phenylalanine at position 50...
- nih.gov
Cystic fibrosis with a heterozygous F508del mutation in the CFTR gene describes an autosomal recessive multisystem disorder in patients who possess a single copy of the class II F508del variant paired with another disease-causing mutation on the second CFTR allele Pathophysiologically, the deletion of phenylalanine at position 508 impairs protein folding and trafficking to the apical plasma membrane, causing viscous secretions, impaired mucociliary clearance, chronic sinopulmonary infections, pr...
- nih.gov
Cystic fibrosis with a heterozygous F508del mutation in the CFTR gene describes an autosomal recessive multisystem disorder in patients who possess a single copy of the class II F508del variant paired with another disease-causing mutation on the second CFTR allele
- hopkinscf.org
This genetic defect disrupts epithelial chloride and bicarbonate transport, primarily damaging the respiratory, gastrointestinal, hepatobiliary, and reproductive tracts
- youtube.com
This genetic defect disrupts epithelial chloride and bicarbonate transport, primarily damaging the respiratory, gastrointestinal, hepatobiliary, and reproductive tracts Pathophysiologically, the deletion of phenylalanine at position 508 impairs protein folding and trafficking to the apical plasma membrane, causing viscous secretions, impaired mucociliary clearance, chronic sinopulmonary infections, progressive bronchiectasis, and exocrine pancreatic insufficiency
Personalize your experience
Follow Cystic fibrosis with heterozygous F508del mutation in CFTR gene and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.